Multimodal treatment with curative intent in a germline BRCA2 mutant metastatic ampullary adenocarcinoma: a case report

BACKGROUND: Cancers of the Vater ampulla (ampullary cancers, ACs) account for less than 1% of all gastrointestinal tumors. ACs are usually diagnosed at advanced stage, with poor prognosis and limited therapeutic options. BRCA2 mutations are identified in up to 14% of ACs and, differently from other...

Descripción completa

Detalles Bibliográficos
Autores principales: Mauri, Gianluca, Gori, Viviana, Patelli, Giorgio, Roazzi, Laura, Rizzetto, Francesco, De Carlis, Luciano, Mariani, Anna, Cavallari, Ugo, Prada, Elisabetta, Cipani, Tiziana, Aquilano, Maria Costanza, Bonoldi, Emanuela, Vanzulli, Angelo, Siena, Salvatore, Sartore-Bianchi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064505/
https://www.ncbi.nlm.nih.gov/pubmed/36998040
http://dx.doi.org/10.1186/s12957-023-02976-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064505/
https://www.ncbi.nlm.nih.gov/pubmed/36998040
http://dx.doi.org/10.1186/s12957-023-02976-0

Ejemplares similares